AstraZeneca to Advance AZD3480 in ADHD
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Bayer submits first-in-class estradiol-based oral contraceptive for approval in the US
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Lundbeck strengthens its research capabilities by acquiring ground-breaking Danish technologies
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
Top 10 Tips for Staying Healthy When Money is Tight
- Details
- Category: Eli Lilly and Company
![Eli Lilly and Company Eli Lilly and Company](http://www.worldpharmanews.com/images/stories/logo/lilly.gif)
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
GSK further extends its product portfolio in the Middle East and North Africa
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
Lu AA24530 shows positive results in major depressive disorder phase II study
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
More Pharma News ...
- Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
- Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
- Bayer files patent infringement lawsuit against Teva
- IRESSA (Gefitinib) Receives Marketing Authorisation in Europe
- Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
- AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
- Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets